Arkolith/Insider Trading/MLTX/Form 4

Reich Kristian

Chief Scientific OfficerMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Sep 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 2, 2025Disposed to issuer(D)49K——35K
Sep 2, 2025Conversion(C)49K——203K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 20, 2025Conversion(C)1K——1K

Transaction Codes

D
Disposition to the issuer
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-084492) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML